IHM
REGN icon

Iguana Healthcare Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Iguana Healthcare Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-7,500
Closed -$2.7M – 99
2016
Q1 		$2.7M Buy
+7,500
New +$3.09M 0.99% 31
2014
Q4 		– Sell
-10,000
Closed -$3.6M – 69
2014
Q3 		$3.6M Buy
+10,000
New +$3.35M 1.93% 15

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return

Iguana Healthcare Management's REGN Position: Q1 2017 in Review

Iguana Healthcare Management sold out of Regeneron Pharmaceuticals (REGN) in Q1 2017, closing a stake of 5,001 shares — an estimated $1.84M sold.

Iguana Healthcare Management first reported a position in REGN in Q1 2016 and held it in 2 quarters. The position peaked at $2.7M in Q1 2016. 579 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • Iguana Healthcare Management reported no remaining Regeneron Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Iguana Healthcare Management sold 5,001 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $1.84M.
  • Iguana Healthcare Management first reported a position in Regeneron Pharmaceuticals in Q1 2016 and held it in 2 quarters.
  • Iguana Healthcare Management's Regeneron Pharmaceuticals position peaked at $2.7M in Q1 2016.
  • 579 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Iguana Healthcare Management's 13F filing for Q1 2017, filed 15 May 2017.